Upstream Bio, Inc.
NASDAQ: UPB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- E. Rand Sutherland
- Employees
- 52
- Headquarters
- Waltham, United States
- IPO year
- 2024
- Market cap
- $345.6M
- Website
- https://upstreambio.com
Loading UPB…
Loading profile data…Frequently asked questions about UPB
What does Upstream Bio, Inc. (UPB) do?
Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin rec...
Where does UPB trade?
Upstream Bio, Inc. (UPB) trades on the NASDAQ Global Select.
What sector is UPB in?
Upstream Bio, Inc. (UPB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Upstream Bio, Inc.?
E. Rand Sutherland is the chief executive officer of Upstream Bio, Inc. (UPB).
Where is Upstream Bio, Inc. headquartered?
Upstream Bio, Inc. is headquartered in United States.
Does UPB pay a dividend?
Upstream Bio, Inc. (UPB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did UPB go public?
Upstream Bio, Inc. (UPB) completed its initial public offering in 2024.